As most metabolites in our bodies originate from exposures such as diet and prescribed drugs, routine drug monitoring is critical to ensuring patient safety and their response to treatment. Professor Philip Britz-McKibbin and his team have developed a new technique that overcomes the throughput limitations of traditional drug screening methods while maintaining accuracy and data quality.